The abstract is read at the publisher; the summary is JClub's.
Asn deamidation of GAD65 generates DRB1*03:01-restricted neoepitopes, with three deamidated and four unmodified peptides eliciting T-cell responses in type 1 diabetes.
- Why it matters: DRB1*03:01 is linked to GAD65 autoantibodies and GAD65 therapy effects, yet few DRB1*03:01-restricted GAD65 epitopes were reliably defined.
- What they did: The study mapped wild-type and Asn-deamidated GAD65 peptides predicted to bind DRB1*03:01 and tested immunogenicity using in vitro CD4+ T-cell assays, isolating T-cell clones/lines for each epitope.
- The result: T cells recognized Asn-deamidated epitopes with higher affinity than unmodified epitopes, and islet-derived T cells from pancreatic organ donors with type 1 diabetes recognized both forms, enabling tracking during progression and clinical trials.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.